Purchase Order 75F40123P00423
Award Date 9/18/23
Potential Completion Date 3/28/25
Potential Value $229K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Midland, MI, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Impact Analytical Inc. has been awarded a $220,792 firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration to conduct benzene screening of drug products. This small business set-aside contract supports the FDA's efforts to test over-the-counter drug products for contaminants and ensure their safety. Impact Analytical will screen samples for benzene at their laboratory in Silver Spring, Maryland, with work expected to be completed by...
- This is a $247,150.00 firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration to Impact Analytical Inc., a for-profit limited liability company. The contract is for the development of a validated analytical method and screening for diethylene glycol/ethylene glycol in over-the-counter children's cough syrup. The contract has a completion date of March 28, 2025. Impact Analytical Inc. is a full-service contract analytical laboratory...
- This federal contract award, with the ID 75F40124P00447, was issued by the Food and Drug Administration (FDA), a civilian agency, to Element Materials Technology Holding USA Inc. The $210,400.00 firm fixed-price purchase order is for the screening of sterile over-the-counter (OTC) monograph drug products for microbial contamination. The contract has an ultimate completion date of September 29, 2025, and was awarded on September 10, 2024. The place of performance is Hamilton, OH. This contract...
- The Food and Drug Administration (FDA) awarded a $186.7K firm fixed-price purchase order to Element Materials Technology Holding USA Inc. on August 27, 2025, for screening sterile over-the-counter (OTC) monograph products for microbial contamination. The contract, with a performance location in Concord, California, is scheduled for completion by September 15, 2026, and carries no set-aside designation, indicating competitive procurement. Element Materials Technology, doing business as Element...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Ama Analytical Services, Inc., a small business located in Lanham, Maryland. The $794,470 contract is for testing official samples of talc-containing cosmetics for asbestiform particles. The contract has a period of performance ending on September 13, 2027. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. Ama Analytical Services, Inc. is a...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Element Materials Technology ANN Arbor LLC, doing business as Avomeen Analytical Services, on September 21, 2021. The contract, which does not have a set-aside designation, is for the analysis of Adderall and generic versions of the drug, with an ultimate completion date of September 20, 2026. The ceiling value of the contract is $362,400.00. Avomeen Analytical...
- This is a $180,000 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and medical research databases and analytics tools. The contract is for data acquisition services related to active pharmaceutical ingredients (APIs), including information on API manufacturing facilities and activities. This single-award contract has a completion date of September 24, 2021....
- The U.S. Food and Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) awarded a firm-fixed-price purchase order contract to Measurements Inc., a for-profit organization, for CDRH-2024-122027 Leakage Testing in Microfluidic Devices. The contract has a ceiling value of $29,486.00 and a completion date of July 4, 2025. The contract was not set aside for any specific business type. The contract originated from a solicitation posted on May 23, 2023, with a due date of June...
- The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Element Materials Technology ANN Arbor LLC, doing business as Avomeen Analytical Services. The contract, valued at $11,000.00, is for analytical characterization services. The services provided under this contract will involve laboratory analysis to characterize and quantify chemical constituents in materials, including leachate from electronic cigarette components and pharmaceuticals. The...